Regeneron Pharmaceuticals Inc (REGN)
982.29
+14.31
(+1.48%)
USD |
NASDAQ |
May 17, 16:00
982.60
+0.31
(+0.03%)
After-Hours: 20:00
Regeneron Pharmaceuticals Gross Profit (Quarterly): 2.711B for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 2.711B |
December 31, 2023 | 2.917B |
September 30, 2023 | 2.926B |
June 30, 2023 | 2.753B |
March 31, 2023 | 2.705B |
December 31, 2022 | 2.874B |
September 30, 2022 | 2.618B |
June 30, 2022 | 2.560B |
March 31, 2022 | 2.560B |
December 31, 2021 | 3.969B |
September 30, 2021 | 3.000B |
June 30, 2021 | 4.445B |
March 31, 2021 | 2.221B |
December 31, 2020 | 2.070B |
September 30, 2020 | 2.02B |
June 30, 2020 | 1.676B |
March 31, 2020 | 1.611B |
December 31, 2019 | 1.642B |
September 30, 2019 | 1.518B |
June 30, 2019 | 1.432B |
March 31, 2019 | 1.200B |
December 31, 2018 | 262.10M |
September 30, 2018 | 1.553B |
June 30, 2018 | 1.516B |
March 31, 2018 | 1.397B |
Date | Value |
---|---|
December 31, 2017 | 1.477B |
September 30, 2017 | 1.396B |
June 30, 2017 | 1.367B |
March 31, 2017 | 1.235B |
December 31, 2016 | 1.152B |
September 30, 2016 | 1.176B |
June 30, 2016 | 1.144B |
March 31, 2016 | 1.089B |
December 31, 2015 | 987.25M |
September 30, 2015 | 1.028B |
June 30, 2015 | 909.78M |
March 31, 2015 | 785.66M |
December 31, 2014 | 742.86M |
September 30, 2014 | 670.20M |
June 30, 2014 | 619.32M |
March 31, 2014 | 582.17M |
December 31, 2013 | 562.30M |
September 30, 2013 | 558.45M |
June 30, 2013 | 418.03M |
March 31, 2013 | 410.61M |
December 31, 2012 | 384.43M |
September 30, 2012 | 407.54M |
June 30, 2012 | 282.56M |
March 31, 2012 | 219.49M |
December 31, 2011 | 119.99M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
1.432B
Minimum
Jun 2019
4.445B
Maximum
Jun 2021
2.511B
Average
2.589B
Median
Gross Profit (Quarterly) Benchmarks
Vertex Pharmaceuticals Inc | 2.348B |
Eli Lilly and Co | 7.094B |
Moderna Inc | 71.00M |
Amgen Inc | 4.247B |
Gilead Sciences Inc | 5.134B |